Health Condition 1: A15-A19- Tuberculosis
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
ICMR - Indian Council Of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Quantitative Component: 1. Newly diagnosed Drug Sensitive TB patients aged 18 years and above registered under the National TB Elimination Program NTEP receiving treatment under NTEP in Government Facility 2. Previously treated patients Recurrent TB and Lost to follow up cases who have been diagnosed subsequently with Drug Sensitive TB aged 18 years and above registered under the National TB Elimination Program NTEP receiving treatment under NTEP in Government Facility 3. Who are willing to provide written informed consent 4. Residing in the study area for treatment duration Qualitative Component: For Patients: 1.Newly diagnosed drug sensitive TB patients aged 18 years and above DS TB registered under the National TB Elimination Program NTEP receiving treatment from the Government Facility 2. Previously treated patients Recurrent TB and Lost to follow up cases who have been diagnosed subsequently with Drug Sensitive TB aged 18 years and above registered under the National TB Elimination Program NTEP receiving treatment under NTEP in Government Facility 3. Who are willing to provide written informed consent 4. Residing in the study area for treatment duration For Healthcare Providers: 1. Directly involved in TB care Healthcare Providers Medical Officers CHOs NTEP Personnel TB Field Staffs and Treatment Supervisors 2. Six months experience in TB program implementation For TB Mitras: 1. Active Mitras Currently supporting one or more NTEP registered patient 2. Former Mitras Discontinued support within the last six months
Exclusion criteria
Exclusion criteria: Quantitative component: 1. Newly diagnosed Drug-Resistant TB patients. 2. Previously treated patients (Treatment failure and Unknown) 3. TB patients co-infected with HIV 4. Severe comorbidities interfering with participation (e.g., severe mental illness, terminal illnesses). 5. Unable to provide informed consent due to cognitive impairment or other reasons. Qualitative Component: For Patients: 1. Previously treated patients (Treatment failure and Unknown) 2. TB patients co-infected with HIV 3. Severe comorbidities (e.g., advanced HIV, cancer) affecting ability to participate 4. Drug-resistant TB (DR-TB) patients For Healthcare Workers (HCWs): Nil For TB Mitras: Nil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative: Treatment outcome at 6 months: proportion of patients who are cured or have completed treatment versus unfavorable outcome. Qualitative: Identification of barriers and facilitators to scheme enrollment, adherence, and engagement (NPY, Nikshay Mitra) as experienced by patients, providers, and Mitras Thematic categories of systemic, community, and operational challenges Change in awareness, perceptions, and reasons for participation or non-participationTimepoint: Quantitative:At 6 months Qualitative: At 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Epidemiological factors affecting treatment outcome Treatment adherence (measured by MARS-5 score) at baseline and end of treatment Rate and timing of Nikshay Poshan Yojana (NPY) benefit receipt Diagnostic delay (time from first healthcare contact to diagnosis and NTEP registration) Association of patient factors and NPY utilization with treatment outcome Awareness and participation in welfare schemesTimepoint: 0 months (enrollment), 6 months (end of treatment), 12 months (follow-up for relapse and ongoing engagement)0 months (enrollment), 6 months (end of treatment), 12 months (follow-up for relapse and ongoing engagement) | — |
Countries
India
Contacts
Public ContactSneha D Mallya
Kasturba Medical College, Manipal, Manipal Institute of Higher Education
Outcome results
None listed